Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Solution for Faster and More Effective Drug Delivery
One of the main challenges with drug delivery and the overall effectiveness of the drugs is first-pass metabolism/excretion Lexaria solves this problem with its DehydraTECH(TM) drug delivery technologySince the company began working on this technology back in 2014, it has made major strides in the delivery of hypertension and anti-viral treatments Since its inception, Lexaria Bioscience (NASDAQ: LEXX) has remained committed to enhancing the speed and…